Company intelligence / Profile preview

Icogenex

Seattle, Washington, USA

Ownership: Private
Development stage: Other

Overview

Icogenex is a private biotechnology company specializing in the identification and development of protein therapeutics for human disease. The company has proven capabilities in expressing proteins from bacteria, yeast, and mammalian cells. It partners with pharmaceutical companies for contract research services and also pursues internal drug development projects. Additionally, it operates a biotech incubator providing lab space to startups.

Therapeutic areas: Other
Modalities: ProteinRecombinant protein
Industry: Biotech

Partnerships

Collaborates with pharmaceutical companies for contract research services

Beyond the preview

Go deeper on Icogenex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Icogenex.

Explore the full profile